FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

930008011000036109: Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial (trade product unit of use)


Status: current, Defined. Date: 31-May 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
967630011000036114 Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial en Synonym Active Case sensitive Australian Medicines Terminology module
967631011000036119 Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial has Australian BoSS canakinumab true Inferred relationship Some 1632972188
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Is a trade product unit of use true Inferred relationship Some
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Is a Ilaris true Inferred relationship Some
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Is a canakinumab 150 mg injection, vial true Inferred relationship Some
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial has manufactured dose form powder for injection true Inferred relationship Some
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial has intended active ingredient canakinumab true Inferred relationship Some 1632972188
Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial has unit of use vial true Inferred relationship Some 1632972189

Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaris 150 mg powder for injection, 4 vials has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris 150 mg powder for injection, 1 vial has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris 150 mg powder for injection, 4 vials has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris 150 mg powder for injection, 1 vial has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris (1 x 150 mg vial, 1 x inert diluent vial), 1 pack has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris (1 x 150 mg vial, 1 x inert diluent vial), 1 pack has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 1
Ilaris (4 x 150 mg vials, 4 x inert diluent vials), 1 pack has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 2
Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) has TPUU True Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial Inferred relationship Some 2

Reference Sets

Trade product unit of use reference set

Back to Start